Wired

Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Mar 4, 2025 - 02:00
Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
Read More

Tags:

Previous Article

Millwall deplore Roberts abuse after Mateta incident

Next Article

Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The Trump Memecoin’s ‘Money-Grab’ Economics

The Trump Memecoin’s ‘Money-Grab’ Economics

Jan 22, 2025

Europe’s Innovation Ecosystem Can Make It the New Palo Alto

Europe’s Innovation Ecosystem Can Make It the New Palo ...

Oct 14, 2024

Inside Two Years of Turmoil at Big Tech's Anti-Terrorism Group

Inside Two Years of Turmoil at Big Tech's Anti-Terroris...

Sep 30, 2024